Aphena Pharma Solutions Inc.
Latest From Aphena Pharma Solutions Inc.
Sterling Pharma Solutions completes an expansion of its UK pilot plant facility, Aphena invests, Dr Reddy’s and Asymchem get nods from the FDA, Ampersand Capital Partners acquires Germany’s Vibalogics, and Xellia strikes a deal with Civica Rx.
Recent portrayals of drug GMP enforcement activity in reports to stockholders ran the gamut from acknowledging the likelihood of adverse financial impacts to suggesting that remediation in response to 483s must be going well because there hasn’t been a warning letter.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.